Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2018
NICE U turn on Opdivo for skin cancer recurrence
30 November 2018 - NHS use of Bristol-Myers Squibb’s Opdivo to cut the risk of early stage skin cancer recurrence ...
Posted by Michael Wonder on 30 Nov 2018
Proposal involving treatments for multiple sclerosis, narcolepsy and attention deficit hyperactivity disorder
30 November 2018 - PHARMAC is seeking feedback on a proposal involving the following products through a provisional agreement with ...
Posted by Michael Wonder on 30 Nov 2018
Decision to fund ceftriaxone in the community for suspected meningococcal disease
30 November 2018 - PHARMAC has widened funded access to ceftriaxone to enable its use for the treatment of suspected ...
Posted by Michael Wonder on 29 Nov 2018
Decision to remove funding restrictions for alendronate 70 mg products, decrease price, and award sole supply
30 November 2018 - PHARMAC is pleased to announce that the funding restrictions on alendronate 70 mg products will be ...
Posted by Michael Wonder on 29 Nov 2018
Five more cancer drugs go on the PBS
30 November 2018 - Australian cancer sufferers will have greater and more affordable access to five treatments from Saturday. ...
Posted by Michael Wonder on 29 Nov 2018
Life extending treatment for patients with advanced liver cancer recommended by NICE
29 November 2018 - Approving regorafenib is a "welcome step forward" for those people who are eligible. ...
Posted by Michael Wonder on 29 Nov 2018
Support for ending and managing HIV
29 November 2018 - The Australian Government is strengthening its commitment to ending HIV with the announcement of funding for a ...
Posted by Michael Wonder on 28 Nov 2018
NICE publishes FAD for new indication for Xeljanz
28 November 2018 - NICE has published a final appraisal document for tofacitinib citrate for the treatment of patients with ...
Posted by Michael Wonder on 28 Nov 2018
First children set to receive Novartis’ Kymriah
27 November 2018 - The first children to receive Novartis’ Kymriah – a ‘game-changing’ CAR-T therapy for cancer - will ...
Posted by Michael Wonder on 27 Nov 2018
Pharma agrees to 2 percent cap on branded meds growth
25 November 2018 - The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price ...
Posted by Michael Wonder on 27 Nov 2018
NHS saves record £300 million by switching to cheaper arthritis drug
26 November 2018 - The NHS is set to save a record £300 million after negotiating deals with five manufacturers ...
Posted by Michael Wonder on 26 Nov 2018
We're paying $834 million more for health insurance but getting less
26 November 2018 - Australians paid $834 million more for health insurance in 2017-18 compared to the year before, despite ...
Posted by Michael Wonder on 26 Nov 2018
Government orders urgent meningococcal vaccination programme for Northland
26 November 2018 - The NZ Government is launching an urgent immunisation programme to fight an outbreak of meningococcal disease ...
Posted by Michael Wonder on 26 Nov 2018
Customers ditch, downgrade private health insurance as premium increases bite: ACCC
26 November 2018 - The proportion of Australians with private health insurance fell last financial year, as premium increases continued ...
Posted by Michael Wonder on 26 Nov 2018
UK pharma industry reacts to outcome of European Council meeting
25 November 2018 - The European Council has endorsed the Agreement on the withdrawal of the UK from the EU and ...